FJ Picard, MG Bergeron. Rapid diagnosis of bacterial infections using technologies based on nucleic acid detection. Can J Infect Dis 1999; tO(Suppl C): 16C-24C.Bacterial identification and antibiotic susceptibility testing methods used in clinical microbiology laboraLOries generally require at least two days. Th is long delay often forces physicians to treat patients presumptively with broad-spectrum antibiotics. Novel diagnostic tests based on the detection of nucleic acids (DNA or RNA) offer a great potential for the rapid (approximately l h) diagnosis of bacterial infections. The present article reviews various aspects of the development and validation of nucleic acid-based assays suitable for the detection and identification of bacteria as well as for the detection of associated antibiotic resistance genes. The potential of these assays for routine use in clinical microbiology laboratories is also discussed.
Key Words: Bacterial i!J/ections; DNA; Genetic methods; Nucleic acids; Rapid diagnosis; RNADiagnostic ra pide des infections bacterien nes au moyen de techniques basees sur la detection des aci des nucleiques RESUME : Les methodes couramment utilisees dans les laboratoires de microbiologie clinique pour !'identification bacterienne et pour la determination de la sensibilite aux antibiotiques requierent en general au moins deux jours. Ce long delai force frequemment !es medecins ii traiter !es patients de fa~on presomptive avec des antibiotiques ii large spectre. De nouveaux tests diagnostiques bases sur la detection des acides nucleiques (ADN ou ARN) pourraient s·averer une excellence alternative pour le diagnostic rapide (environ une heure) des infections bacteriennes. Cet article presente une revue des differentes etapes du developpement et de la validation d'essais reconnaissant specifiquement ces acides nucleiques pour la detection et !'identification de bacteries ainsi que pour la detection de genes de resistance associes. L'applicalion clinique de ces essais pour usage dans !es laboratoires de microbiologie clinique est egalement discutee. I nfectious diseases are responsible for more than 17 million deaths worldwide per year, and bacterial infections are the cause of a high percentage of these infections (1,2). The emergence of antibiotic resistance in bacteria is an increasingly serious problem that complicates treatment. The inappropriate use of antibiotics and the use of broad spectrum antibiotics are associated with this increasing rate of resistance (3).Clearly, the health care costs associated with bacterial infections are enormous and growing.The usefulness of clinical microbiology laboratory results provided to practicing physicians is highly dependent on timely identification and susceptibility testing of microbial pathogens. While other laboratories, such as biochemistry and hematology laboratories, provide clinically relevant re-